Anticoagulant therapy for NV atrial fibrillation: multiple considerations come into play when choosing anticoagulant therapy for nonvalvular atrial fibrillation, a condition that increases the risk for stroke

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The clinical advisor 2016-02, p.27
Hauptverfasser:	Lenahan, Christy McDonald, Harrington, Deedra
Format:	Magazinearticle
Sprache:	eng
Schlagworte:	Anticoagulants (Medicine) Associations, institutions, etc Atrial fibrillation Care and treatment Evidence-based medicine Pharmaceutical industry Risk factors Societies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page	27
container_title	The clinical advisor
container_volume
creator	Lenahan, Christy McDonald Harrington, Deedra
description
format	Magazinearticle
fullrecord	<record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A443551925</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A443551925</galeid><sourcerecordid>A443551925</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1055-46435e65509f9a4d96cca94e276f7118d789876f9b0bc8603202199eba069553</originalsourceid><addsrcrecordid>eNp1UMlOwzAQzQEkSuEfLHElyEnsJOZWVWxSBZeKazVxJqmpY1e2W9S_5JNwgAuiaA6zvUUzJ8kk4zlLqyKrzpJz798oZYwVxST5mJmgpIV-p8EEEtboYHsgnXXk-ZVAcAo06VTjlNYQlDW3ZNjpoLYaibTGqzYSxrmP7YBEmWDJVsOBvK_RELm21ivTE_jXxlizB72PC3fM75rAaNSqsYlECNFDOgSPftQhTvnNl5APzm7wIjntQHu8_MnTZHl_t5w_pouXh6f5bJH2GeU8ZSUrOJacU9EJYK0opQTBMK_Krsqyuq1qUcdaNLSRdUmLnOaZENgALQXnxTS5-pbtQeNKmc4GB3JQXq5m8bOcZyIfUekRVI8mnq-twU7F8S_8zRF8jBaH-L6_hE_osJld</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>magazinearticle</recordtype></control><display><type>magazinearticle</type><title>Anticoagulant therapy for NV atrial fibrillation: multiple considerations come into play when choosing anticoagulant therapy for nonvalvular atrial fibrillation, a condition that increases the risk for stroke</title><source>Alma/SFX Local Collection</source><creator>Lenahan, Christy McDonald ; Harrington, Deedra</creator><creatorcontrib>Lenahan, Christy McDonald ; Harrington, Deedra</creatorcontrib><identifier>ISSN: 1524-7317</identifier><language>eng</language><publisher>Haymarket Media, Inc</publisher><subject>Anticoagulants (Medicine) ; Associations, institutions, etc ; Atrial fibrillation ; Care and treatment ; Evidence-based medicine ; Pharmaceutical industry ; Risk factors ; Societies</subject><ispartof>The clinical advisor, 2016-02, p.27</ispartof><rights>COPYRIGHT 2016 Haymarket Media, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780</link.rule.ids></links><search><creatorcontrib>Lenahan, Christy McDonald</creatorcontrib><creatorcontrib>Harrington, Deedra</creatorcontrib><title>Anticoagulant therapy for NV atrial fibrillation: multiple considerations come into play when choosing anticoagulant therapy for nonvalvular atrial fibrillation, a condition that increases the risk for stroke</title><title>The clinical advisor</title><subject>Anticoagulants (Medicine)</subject><subject>Associations, institutions, etc</subject><subject>Atrial fibrillation</subject><subject>Care and treatment</subject><subject>Evidence-based medicine</subject><subject>Pharmaceutical industry</subject><subject>Risk factors</subject><subject>Societies</subject><issn>1524-7317</issn><fulltext>true</fulltext><rsrctype>magazinearticle</rsrctype><creationdate>2016</creationdate><recordtype>magazinearticle</recordtype><sourceid/><recordid>eNp1UMlOwzAQzQEkSuEfLHElyEnsJOZWVWxSBZeKazVxJqmpY1e2W9S_5JNwgAuiaA6zvUUzJ8kk4zlLqyKrzpJz798oZYwVxST5mJmgpIV-p8EEEtboYHsgnXXk-ZVAcAo06VTjlNYQlDW3ZNjpoLYaibTGqzYSxrmP7YBEmWDJVsOBvK_RELm21ivTE_jXxlizB72PC3fM75rAaNSqsYlECNFDOgSPftQhTvnNl5APzm7wIjntQHu8_MnTZHl_t5w_pouXh6f5bJH2GeU8ZSUrOJacU9EJYK0opQTBMK_Krsqyuq1qUcdaNLSRdUmLnOaZENgALQXnxTS5-pbtQeNKmc4GB3JQXq5m8bOcZyIfUekRVI8mnq-twU7F8S_8zRF8jBaH-L6_hE_osJld</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Lenahan, Christy McDonald</creator><creator>Harrington, Deedra</creator><general>Haymarket Media, Inc</general><scope/></search><sort><creationdate>20160201</creationdate><title>Anticoagulant therapy for NV atrial fibrillation: multiple considerations come into play when choosing anticoagulant therapy for nonvalvular atrial fibrillation, a condition that increases the risk for stroke</title><author>Lenahan, Christy McDonald ; Harrington, Deedra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1055-46435e65509f9a4d96cca94e276f7118d789876f9b0bc8603202199eba069553</frbrgroupid><rsrctype>magazinearticle</rsrctype><prefilter>magazinearticle</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anticoagulants (Medicine)</topic><topic>Associations, institutions, etc</topic><topic>Atrial fibrillation</topic><topic>Care and treatment</topic><topic>Evidence-based medicine</topic><topic>Pharmaceutical industry</topic><topic>Risk factors</topic><topic>Societies</topic><toplevel>online_resources</toplevel><creatorcontrib>Lenahan, Christy McDonald</creatorcontrib><creatorcontrib>Harrington, Deedra</creatorcontrib><jtitle>The clinical advisor</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lenahan, Christy McDonald</au><au>Harrington, Deedra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticoagulant therapy for NV atrial fibrillation: multiple considerations come into play when choosing anticoagulant therapy for nonvalvular atrial fibrillation, a condition that increases the risk for stroke</atitle><jtitle>The clinical advisor</jtitle><date>2016-02-01</date><risdate>2016</risdate><spage>27</spage><pages>27-</pages><issn>1524-7317</issn><pub>Haymarket Media, Inc</pub></addata></record>
fulltext	fulltext
identifier	ISSN: 1524-7317
ispartof	The clinical advisor, 2016-02, p.27
issn	1524-7317
language	eng
recordid	cdi_gale_infotracmisc_A443551925
source	Alma/SFX Local Collection
subjects	Anticoagulants (Medicine) Associations, institutions, etc Atrial fibrillation Care and treatment Evidence-based medicine Pharmaceutical industry Risk factors Societies
title	Anticoagulant therapy for NV atrial fibrillation: multiple considerations come into play when choosing anticoagulant therapy for nonvalvular atrial fibrillation, a condition that increases the risk for stroke
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A25%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticoagulant%20therapy%20for%20NV%20atrial%20fibrillation:%20multiple%20considerations%20come%20into%20play%20when%20choosing%20anticoagulant%20therapy%20for%20nonvalvular%20atrial%20fibrillation,%20a%20condition%20that%20increases%20the%20risk%20for%20stroke&rft.jtitle=The%20clinical%20advisor&rft.au=Lenahan,%20Christy%20McDonald&rft.date=2016-02-01&rft.spage=27&rft.pages=27-&rft.issn=1524-7317&rft_id=info:doi/&rft_dat=%3Cgale%3EA443551925%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A443551925&rfr_iscdi=true